TELA Bio, Inc. (TELA) Misses Q1 EPS by 9c

TELA Bio, Inc. (NASDAQ: TELA) reported Q1 EPS of ($0.63), $0.09 worse than the analyst estimate of ($0.54). Revenue for the quarter came in at $11.9 million versus the consensus estimate of $11.91 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• UBS says bull market has further to run
• S&P 500 may pull back before midterms, but Citi says buy the dip